Hyperliquid's total value locked (TVL) across its Layer 1 network and Arbitrum reached $7.402 billion as of September 25, 2026, with $6.82 billion on Hyperliquid L1 and $581.55 million on Arbitrum. The ecosystem generated $76.13 million in fees and $59.33 million in protocol revenue over the past 30 days, highlighting robust activity in its decentralized perpetual-futures exchange and related markets. With over $548 billion in cumulative trading volume since launch and nearly 235 million HYPE tokens circulating, Hyperliquid continues to expand its DeFi presence. CEO David Schamis emphasized the protocol's success in generating real fees, indicating strong potential for future growth and adoption.
Hyperliquid's total value locked (TVL) reached $7.402 billion across its Layer 1 network and Arbitrum as of September 25, 2026. For readers following Hyperliquid, here is Pluang's market snapshot as of Sep 25, 2026 03:01 WIB: 44 of 50 major cryptocurrencies rose today, with CAKE up 7.23% at Rp49.273, DOT up 7.17% at Rp20.944, and SAND up 6.86% at Rp768. Typical hold times ranged from 75 to 123 days, with varied Pluang order activity percentages.
Costco reported a strong Q4 earnings per share (EPS) of $6.75, surpassing analyst expectations of $6.54, helped by tariff refunds. Although quarterly revenue of $93.87 billion slightly missed the $94.97 billion forecast, net sales rose 11.2% year-ove...
Vistry Group reported a significant first-half pre-tax loss of £661.3 million, driven by a £475 million goodwill impairment and increased building safety costs. Revenue fell to £1.42 billion, and operational performance weakened with fewer home compl...
Vail Resorts is set to report its Q3 2026 earnings on September 28, with analysts forecasting a loss per share around -$5.30 and revenue near $271 million, indicating flat performance year-over-year. The company’s financial health shows a high Debt-t...
REGENXBIO announced positive 3-year results from its Phase II ALTITUDE trial of surabgene lomparvovec (sura-vec) for non-proliferative diabetic retinopathy (NPDR). A single in-office gene therapy dose led to over 60% of participants achieving more th...
Ethereum (ETH) has printed its first higher high since its August 2025 peak, breaking a year-long pattern of lower highs. It surpassed the $2,438 resistance level, which has now turned into support, signaling a more bullish weekly structure. However,...
